{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:53Z","timestamp":1788322673795,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gertrud Thalmann Foundation of the University Psychiatric Clinics Basel"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jad.2025.119504","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T19:10:50Z","timestamp":1748286650000},"page":"119504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Adjunctive d-serine treatment for major depressive disorder: A randomized clinical trial"],"prefix":"10.1016","volume":"387","author":[{"given":"Lukas","family":"Sempach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Chiara","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette B.","family":"Br\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Sterzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119504_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2016.00169","article-title":"On or off?: modulating the N-methyl-D-aspartate receptor in major depression","volume":"9","author":"Chan","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.jad.2025.119504_bb0010","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41386-019-0480-y","article-title":"Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo\u2013control study","volume":"44","author":"Chen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jad.2025.119504_bb0015","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/ph17121618","article-title":"N-methyl-D-aspartate receptors and depression: linking psychopharmacology, pathology and physiology in a unifying hypothesis for the epigenetic code of neural plasticity","volume":"17","author":"Comai","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.jad.2025.119504_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jad.2025.119504_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br. J. Soc. Clin. Psychol."},{"key":"10.1016\/j.jad.2025.119504_bb0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-4939-7228-9_16","article-title":"The glutamatergic system as potential clinical biomarkers for blood and cerebrospinal fluid monitoring","volume":"130","author":"Hashimoto","year":"2018","journal-title":"Neuromethods"},{"issue":"12","key":"10.1016\/j.jad.2025.119504_bb0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2009.01.002","article-title":"Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine","volume":"65","author":"Hashimoto","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.119504_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/neu.2015.59","article-title":"Increased serum levels of serine enantiomers in patients with depression","volume":"28","author":"Hashimoto","year":"2016","journal-title":"Acta Neuropsychiatrica"},{"issue":"1","key":"10.1016\/j.jad.2025.119504_bb0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41380-023-02312-8","article-title":"Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders","volume":"29","author":"Heresco-Levy","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2025.119504_bb0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2004.12.037","article-title":"D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia","volume":"57","author":"Heresco-Levy","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.119504_bb0055","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1017\/S1461145709000339","article-title":"Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder","volume":"12","author":"Heresco-Levy","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2025.119504_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145712000910","article-title":"A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression","volume":"16","author":"Heresco-Levy","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2025.119504_bb0065","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.conb.2012.01.007","article-title":"Synaptic plasticity of NMDA receptors: mechanisms and functional implications","volume":"22","author":"Hunt","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jad.2025.119504_bb0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jad.2017.09.035","article-title":"Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity","volume":"226","author":"Ishiwata","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.jad.2025.119504_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2010.05.012","article-title":"High dose D-serine in the treatment of schizophrenia","volume":"121","author":"Kantrowitz","year":"2010","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.jad.2025.119504_bb0080","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of d-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.119504_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpsychires.2014.12.007","article-title":"Behavioral and cognitive effects of the N-methyl-d-aspartate receptor co-agonist d-serine in healthy humans: initial findings","volume":"61","author":"Levin","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.jad.2025.119504_bb0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ijnp\/pyac006","article-title":"Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: a randomized, double-blind, sertraline- and placebo-controlled trial","volume":"25","author":"Lin","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.jad.2025.119504_bb0095","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1017\/S1461145711001386","article-title":"Acute D-serine treatment produces antidepressant-like effects in rodents","volume":"15","author":"Malkesman","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.119504_bb0100","article-title":"D-serine: a cross species review of safety","volume":"12","author":"Meftah","year":"2021","journal-title":"Front. Psych."},{"issue":"6","key":"10.1016\/j.jad.2025.119504_bb0105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2025.119504_bb0110","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies","volume":"24","author":"Moriguchi","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.119504_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","article-title":"Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists","volume":"150","author":"Papouin","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jad.2025.119504_bb0120","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/npp.2015.319","article-title":"D-amino-acid oxidase inhibition increases D-serine plasma levels in mouse but not in monkey or dog","volume":"41","author":"Rojas","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.119504_bb0125","first-page":"1","article-title":"Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials","volume":"2024","author":"Saelens","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jad.2025.119504_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.jad.2025.119504_bb0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11064-016-1838-8","article-title":"Modulating NMDA receptor function with d-amino acid oxidase inhibitors: understanding functional activity in PCP-treated mouse model","volume":"41","author":"Sershen","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jad.2025.119504_bb0140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2147\/NDT.S119004","article-title":"Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)","volume":"13","author":"Vasilescu","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.jad.2025.119504_bb0145","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2025.119504_bb0150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the Hamilton Depression Rating Scale","volume":"150","author":"Zimmerman","year":"2013","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725009462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725009462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:47:37Z","timestamp":1762249657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725009462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"alternative-id":["S0165032725009462"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119504","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive d-serine treatment for major depressive disorder: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119504"}}